Page last updated: 2024-09-05

3-(2'-pyridyldithio)benzyldiazoacetate and ER-Negative PR-Negative HER2-Negative Breast Cancer

3-(2'-pyridyldithio)benzyldiazoacetate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chan, SH; Chen, YT; Chiu, WY; Luo, YX; Yang, HW1

Other Studies

1 other study(ies) available for 3-(2'-pyridyldithio)benzyldiazoacetate and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Dual antibody-aided mesoporous nanoreactor for H
    Journal of nanobiotechnology, 2023, Oct-24, Volume: 21, Issue:1

    Topics: Antibodies, Monoclonal; B7-H1 Antigen; Humans; Hydrogen Peroxide; Immune Checkpoint Inhibitors; Immunotherapy; Nanotechnology; Triple Negative Breast Neoplasms

2023